CAB Inhibitors

CAB inhibitors is a class of chemical compounds that target and inhibit certain cellular processes, specifically related to the cell cycle and cell division. CAB stands for Cyclin-Dependent Kinase (CDK), Aurora Kinase, and Polo-like Kinase (PLK) inhibitors. These enzymes are crucial regulators of cell division, and their dysregulation is frequently observed in various types of cancer and other proliferative disorders. CAB inhibitors are designed to interfere with the activity of these kinases, ultimately disrupting the normal progression of the cell cycle. Within the class of CAB inhibitors, each subgroup specifically targets one or more of these kinases. Cyclin-Dependent Kinases (CDKs) play a central role in governing the cell cycle by phosphorylating key proteins that drive cell division. CAB inhibitors that focus on CDKs aim to hinder their activity, thus preventing the cell from progressing through the various phases of the cell cycle. Aurora Kinases, on the other hand, are involved in processes like chromosome segregation and cytokinesis. Inhibitors targeting Aurora Kinases seek to induce errors in these processes, leading to cell death or mitotic catastrophe. Polo-like Kinases are essential for multiple aspects of cell division, such as centrosome maturation and spindle assembly. CAB inhibitors targeting PLKs work to disrupt these critical events, ultimately impairing the cell's ability to divide correctly. In summary, CAB inhibitors constitute a diverse class of chemical compounds that hold great promise for their ability to manipulate cellular processes associated with cell division, thereby offering insights into fundamental biology and applications in various fields.